Cape Investment Advisory’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$46.8K Buy
+167
New +$43.9K 0.01% 518
2026
Q1
Sell
-152
Closed -$38.1K 759
2025
Q4
$38.1K Buy
152
+17
+13% +$4.51K 0.01% 479
2025
Q3
$38.8K Sell
135
-2
-1% -$536 0.04% 251
2025
Q2
$36K Buy
137
+1
+0.7% +$244 0.01% 412
2025
Q1
$31.6K Sell
136
-16
-11% -$3.88K 0.01% 408
2024
Q4
$34.9K Buy
152
+10
+7% +$2.29K 0.01% 393
2024
Q3
$31.7K Sell
142
-4
-3% -$879 0.01% 384
2024
Q2
$29.7K Buy
+146
New +$29.7K 0.01% 375
2024
Q1
Sell
-162
Closed -$36.8K 1062
2023
Q4
$36.8K Buy
162
+2
+1% +$420 0.02% 405
2023
Q3
$32.2K Sell
160
-26
-14% -$5.48K 0.02% 366
2023
Q2
$38.6K Buy
186
+7
+4% +$1.36K 0.02% 329
2023
Q1
$35.3K Buy
+179
New +$36.8K 0.02% 329

Other funds holding LH

Cape Investment Advisory's LH Position: Q2 2026 in Review

Cape Investment Advisory opened a new position in Labcorp (LH) in Q2 2026: 167 shares worth $46.8K. The stake represents 0.01% of the portfolio and ranks #518 among its holdings. This is a return to the name: Cape Investment Advisory previously reported a position in LH as recently as Q4 2025.

Cape Investment Advisory first reported a position in LH in Q1 2023 and has held it in 12 quarters since. 265 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Cape Investment Advisory held 167 shares of Labcorp worth $46.8K as of Q2 2026.
  • Labcorp was a new Cape Investment Advisory position in Q2 2026.
  • Labcorp made up 0.01% of Cape Investment Advisory's portfolio in Q2 2026, its #518 holding.
  • Cape Investment Advisory first reported a position in Labcorp in Q1 2023 and has held it in 12 quarters since.
  • 265 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Cape Investment Advisory's 13F filing for Q2 2026, filed 23 Jul 2026.